PubMed · 2002 · 53 citations · 23 references
Life SciencesGeneticsOncologyCancer GeneticsDna RepairMolecular OncologyCancer Molecular PathologyEwing SarcomaGene Fusions In CancerMalignant NeoplasmsTranscription Factor OncogenesTumor Suppressor GenesBrca1 FunctionBreast Cancer Susceptibility Protein 1Chimeric OncogenesEts Family Transcription FactorsEwsr1-ets Fusion ProteinsGenome SurveillanceSarcoma-associated Fusion GenesTumor Suppressor Pathways
In 85% of Ewing family tumors, the NH2 terminus of EWS is fused to the DNA-binding domain of FLI1, an ets transcription factor. The resulting chimeric protein is a strong transcriptional activator with transforming activity. We report that EWS and EWS-FLI1 interact via their common NH2 terminus with the COOH terminus of BARD1, a putative tumor suppressor, in vitro and in vivo. Because BARD1 associates via its NH2-terminal RING domain with the breast cancer susceptibility gene BRCA1 that provides a platform for interactions with proteins involved in DNA repair and checkpoint control, our results provide a link between the Ewing's sarcoma gene product and the genome surveillance complex.
23
Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage
Ralph Scully, Junjie Chen, Robert Ochs et al. · Cell · 1997 · 909 citations · Full text
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
Leeju C. Wu, Zhuo Wei Wang, Julia Tsou Tsan et al. · Nature Genetics · 1996 · 752 citations